Humana Inc (HUM) has released an update to notify the public and investors about a regulation fd disclosure.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On January 31, 2024, the CMS released preliminary 2025 payment rates and policy changes for Medicare Advantage and Part D, with a slight decrease in average benchmark funding of 0.16%. Humana Inc. estimates this will negatively impact their benchmark funding more than expected, due to unanticipated growth rate adjustments and normalization factors proposed by CMS. Despite this, the company maintains its 2025 Adjusted EPS growth outlook, as these rates are not final and industry feedback may influence the final figures.
For further insights into HUM stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.